Patrick C. Walsh

62.1k total citations · 21 hit papers
577 papers, 40.5k citations indexed

About

Patrick C. Walsh is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Patrick C. Walsh has authored 577 papers receiving a total of 40.5k indexed citations (citations by other indexed papers that have themselves been cited), including 418 papers in Pulmonary and Respiratory Medicine, 142 papers in Rheumatology and 109 papers in Surgery. Recurrent topics in Patrick C. Walsh's work include Prostate Cancer Diagnosis and Treatment (355 papers), Prostate Cancer Treatment and Research (317 papers) and Urologic and reproductive health conditions (129 papers). Patrick C. Walsh is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (355 papers), Prostate Cancer Treatment and Research (317 papers) and Urologic and reproductive health conditions (129 papers). Patrick C. Walsh collaborates with scholars based in United States, Sweden and United Kingdom. Patrick C. Walsh's co-authors include Jonathan I. Epstein, Alan W. Partin, Donald S. Coffey, L. L. EWING, P.J. Donker, Misop Han, Leslie A. Mangold, Stephen J. Berry, Elizabeth B. Humphreys and Herbert Lepor and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Patrick C. Walsh

547 papers receiving 38.5k citations

Hit Papers

The Development of Human Benign Prostatic Hyperplasia wit... 1974 2026 1991 2008 1984 2005 1982 1998 2001 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Development of Human Benign Prostatic Hyperplasia with Age
    1984 1.8k citations Patrick C. Walsh et al. The Journal of Urology profile →
  2. Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy
    2005 1.0k citations Stephen J. Freedland, Elizabeth B. Humphreys et al. profile →
  3. Impotence Following Radical Prostatectomy: Insight Into Etiology and Prevention
    1982 1.0k citations Patrick C. Walsh et al. The Journal of Urology profile →
  4. Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease
    1998 860 citations Alan W. Partin, Patrick C. Walsh et al. profile →
  5. LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY
    2001 821 citations Misop Han, Alan W. Partin et al. profile →
  6. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
    2001 755 citations Alan W. Partin, Leslie A. Mangold et al. Urology profile →
  7. Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations
    1983 735 citations Patrick C. Walsh et al. The Prostate profile →
  8. Correlation of pathologic findings with progression after radical retropubic prostatectomy
    1993 618 citations Jonathan I. Epstein, Patrick C. Walsh et al. Cancer profile →
  9. Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate Cancer
    2003 559 citations Misop Han, Alan W. Partin et al. The Journal of Urology profile →
  10. Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years
    1994 555 citations Patrick C. Walsh, Alan W. Partin et al. The Journal of Urology profile →
  11. Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia
    1990 506 citations Alan W. Partin, Jonathan I. Epstein et al. The Journal of Urology profile →
  12. Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
    2011 485 citations Bruce J. Trock, Patricia Landis et al. Journal of Clinical Oncology profile →
  13. Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy
    1988 477 citations Jonathan I. Epstein, Charles B. Brendler et al. The Journal of Urology profile →
  14. Family history and the risk of prostate cancer
    1990 476 citations Terri H. Beaty, Patrick C. Walsh et al. The Prostate profile →
  15. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.
    1993 474 citations Alan W. Partin, Jonathan I. Epstein et al. PubMed profile →
  16. Familial Incomplete Male Pseudohermaphroditism, Type 2
    1974 471 citations Patrick C. Walsh et al. New England Journal of Medicine profile →
  17. Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
    2011 468 citations Patrick C. Walsh, Misop Han et al. The Journal of Urology profile →
  18. Prediction of Progression Following Radical Prostatectomy
    1996 457 citations Jonathan I. Epstein, Alan W. Partin et al. profile →
  19. Prognostic G leason grade grouping: data based on the modified G leason scoring system
    2013 452 citations Patrick C. Walsh, Alan W. Partin et al. profile →
  20. The induction of prostatic hypertrophy in the dog with androstanediol.
    1976 345 citations Patrick C. Walsh et al. profile →
  21. Precise Localization of the Autonomic Nerves From the pelvic Plexus to the Corpora Cavernosa: a Detailed Anatomical Study of the Adult Male Pelvis
    1985 315 citations Patrick C. Walsh et al. The Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick C. Walsh United States 104 29.5k 9.4k 8.0k 7.0k 5.8k 577 40.5k
Peter T. Scardino United States 124 40.7k 1.4× 10.6k 1.1× 10.1k 1.3× 4.2k 0.6× 8.2k 1.4× 738 52.0k
Alan W. Partin United States 94 31.0k 1.1× 7.9k 0.8× 6.5k 0.8× 3.0k 0.4× 7.6k 1.3× 657 40.3k
Peter R. Carroll United States 110 30.7k 1.0× 6.2k 0.7× 10.2k 1.3× 4.1k 0.6× 7.8k 1.3× 880 46.0k
Teuvo L.J. Tammela Finland 69 12.7k 0.4× 3.1k 0.3× 3.7k 0.5× 4.5k 0.6× 6.3k 1.1× 669 24.3k
Jonathan I. Epstein United States 121 46.9k 1.6× 16.6k 1.8× 15.9k 2.0× 5.5k 0.8× 12.3k 2.1× 991 63.6k
William J. Catàlona United States 90 20.9k 0.7× 6.7k 0.7× 8.0k 1.0× 3.5k 0.5× 4.8k 0.8× 547 31.2k
Francesco Montorsi Italy 113 32.9k 1.1× 11.3k 1.2× 18.0k 2.3× 14.9k 2.1× 7.6k 1.3× 1.7k 59.5k
Thomas M. Wheeler United States 95 17.2k 0.6× 6.6k 0.7× 6.0k 0.7× 1.7k 0.2× 5.7k 1.0× 403 29.8k
Eric A. Klein United States 88 19.7k 0.7× 3.5k 0.4× 6.0k 0.8× 2.2k 0.3× 5.0k 0.9× 733 29.8k
Theodorus van der Kwast Netherlands 86 20.0k 0.7× 4.4k 0.5× 7.9k 1.0× 2.2k 0.3× 8.2k 1.4× 651 32.9k

Countries citing papers authored by Patrick C. Walsh

Since Specialization
Citations

This map shows the geographic impact of Patrick C. Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. Walsh more than expected).

Fields of papers citing papers by Patrick C. Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick C. Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. Walsh. The network helps show where Patrick C. Walsh may publish in the future.

Co-authorship network of co-authors of Patrick C. Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick C. Walsh. A scholar is included among the top collaborators of Patrick C. Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick C. Walsh. Patrick C. Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Na, Rong, Jun Wei, Christopher Sample, et al.. (2021). The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients. British Journal of Cancer. 126(5). 791–796. 17 indexed citations
2.
Xu, Jianfeng, William B. Isaacs, Mufaddal Mamawala, et al.. (2021). Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients. The Prostate. 81(10). 703–709. 9 indexed citations
3.
Wu, Yishuo, Hongjie Yu, Shuwei Li, et al.. (2020). Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer. European Urology Oncology. 3(2). 224–230. 38 indexed citations
4.
Helfand, Brian T., Haitao Chen, Richard J Fantus, et al.. (2018). Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score. The Prostate. 78(14). 1063–1068. 1 indexed citations
5.
Ross, Ashley E., Stacy Loeb, Patricia Landis, et al.. (2010). Prostate-Specific Antigen Kinetics During Follow-Up Are an Unreliable Trigger for Intervention in a Prostate Cancer Surveillance Program. Journal of Clinical Oncology. 28(17). 2810–2816. 201 indexed citations
6.
Walsh, Patrick C.. (2010). Anterior-predominant prostatic tumors: Zone of origin and pathologic outcomes at radical prostatectomy. The Journal of Urology. 184(5). 1983–1984. 73 indexed citations
7.
Hsu, Fang‐Chi, Jielin Sun, Fredrik Wiklund, et al.. (2009). A Novel Prostate Cancer Susceptibility Locus at 19q13. Cancer Research. 69(7). 2720–2723. 36 indexed citations
8.
Freedland, Stephen J., Alan W. Partin, Elizabeth B. Humphreys, Leslie A. Mangold, & Patrick C. Walsh. (2007). Radical prostatectomy for clinical stage T3a disease. Cancer. 109(7). 1273–1278. 107 indexed citations
9.
Zheng, S. Lilly, Bao-Li Chang, Jielin Sun, et al.. (2006). Germ-Line Mutation of NKX3.1 Cosegregates with Hereditary Prostate Cancer and Alters the Homeodomain Structure and Function. Cancer Research. 66(1). 69–77. 35 indexed citations
10.
Wu, Christopher L., et al.. (2005). Correlation of Postoperative Pain to Quality of Recovery in the Immediate Postoperative Period. Regional Anesthesia & Pain Medicine. 30(6). 516–522. 125 indexed citations
11.
Pacík, Dalibor & Patrick C. Walsh. (2005). Radikální retropubická prostatektomie - nejúčinnější a nejméně zatěžující metoda pro vyléčení lokalizovaného karcinomu prostaty - II. díl. Urologie pro praxi. 3(6). 252–257. 1 indexed citations
12.
Brown, W. Mark, Ethan M. Lange, S. Lilly Zheng, et al.. (2004). Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci. British Journal of Cancer. 90(2). 510–514. 28 indexed citations
13.
Han, Misop, Alan W. Partin, Derek Y. Chan, et al.. (2004). RE: An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series [3] (multiple letters). The Journal of Urology. 172(2). 2 indexed citations
14.
Barocas, Daniel A., Misop Han, Jonathan I. Epstein, et al.. (2001). Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?. Urology. 58(5). 746–751. 62 indexed citations
15.
Sanda, Martin G., Bruce Binkowitz, Terri H. Beaty, et al.. (1997). Clinical and biological characteristics of familial benign prostatic hyperplasia.. PubMed. 157(3). 32–33. 31 indexed citations
16.
17.
Rifkin, Matthew D., Elias A. Zerhouni, Constantine Gatsonis, et al.. (1991). MRI and ultrasonography in staging prostate cancer (Reply). New England Journal of Medicine. 324(7). 494–495. 4 indexed citations
18.
Walsh, Patrick C.. (1990). Lack of evidence for aromatase in human prostatic tissues: Effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism: Editorial comment. The Journal of Urology. 144(1). 1 indexed citations
19.
Rajfer, Jacob & Patrick C. Walsh. (1978). Testicular descent. Normal and abnormal.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5(1). 223–35. 20 indexed citations
20.
Walsh, Patrick C.. (1975). Physiologic basis for hormonal theapy in carcinoma of the prostate.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(1). 125–40. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter T. Scardino Breakdown of academic impact, for papers by Alan W. Partin Breakdown of academic impact, for papers by Peter R. Carroll Breakdown of academic impact, for papers by Teuvo L.J. Tammela Breakdown of academic impact, for papers by Jonathan I. Epstein Breakdown of academic impact, for papers by William J. Catàlona Breakdown of academic impact, for papers by Francesco Montorsi Breakdown of academic impact, for papers by Thomas M. Wheeler Breakdown of academic impact, for papers by Eric A. Klein Breakdown of academic impact, for papers by Theodorus van der Kwast
Rankless by CCL
2026